Caring Brands, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $12.6M
- Price
- $1.22
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.40%
- Volume
- 12.6K
About
Caring Brands, Inc. operates as a consumer wellness company, offering a varied collection of over-the-counter (OTC) and cosmetic merchandise. Its extensive product catalog features items such as hair loss treatments, solutions for eczema and psoriasis, vitiligo remedies, a specialized sun protection line that defends against jellyfish stings, and intimate health products for women. All these offerings are crafted to fulfill a wide array of health and personal care requirements. The firm was founded in 2020 and is based in Jupiter, Florida.
Quick stats
Shares outstanding10.4M
Computed float9.1M
Float / shares87.7%
Cash runway (months)49.8
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0002020737
Websitehttps://www.Caringbrands.com
AI Summary
AI-generated1/6
standardneutraloffering
Caring Brands Inc. (Nasdaq: CABR) Completes Initial $4.6 Million Closing Under Ongoing $9 Million Private Placement
Caring Brands Inc. completed an initial $4.6 million closing on September 1, 2026 under its ongoing $9.0 million private placement, issuing convertible preferred shares to accredited investors.
An additional $4,400,000 of subscription documents have been executed, and the company expects a further closing on or before September 4, 2026, involving 4,400 Series B preferred shares plus Series A and Series B warrants to purchase up to 4,400,000 common shares each — while cautioning that no assurance exists the additional closing will be completed.
Proceeds will fund the launch of a proprietary salesforce and domestic and international marketing campaigns, which CEO Dr. Glynn Wilson says should enable the company to substantially increase revenues at a quicker pace.
The rolling-close structure with double warrant coverage implies meaningful potential share dilution, and the release also references the company's ongoing effort to regain Nasdaq listing compliance through a Hearings Panel proceeding.
Red flags
- additional $4.4M closing not guaranteed — company states 'No assurance can be given'
- heavy dilution: pending tranche carries two warrant series covering up to 4,400,000 shares each plus convertible preferred
- no per-share pricing terms disclosed for the preferred shares or warrants
- release references effort to regain compliance with Nasdaq listing requirements and pending Hearings Panel proceeding — delisting risk
- micro-cap raise with proceeds tied to unproven marketing/salesforce ramp